The tumor suppressor activity of FXR is likely related to both BA-dependent (i.e., protection from BA-mediated inflammation and toxicity) and BA-independent (i.e., gut permeability, Wnt/β-catenin signaling) functions (142). Here, NR1H4 is linked to neoplasm.